Showing results (1-10 of 72) with videos related to
Sort By:
Pageof 8
Bulletin Du Cancer|June 30, 2024
(Bio)marqueurs de « routine » dans le cancer du rein métastatiqueDelphine BorchielliniBulletin Du Cancer|June 27, 2022
Clinical activity of immunotherapy-based combination first-line therapies for metastatic renal cell carcinoma: the right treatment for the right patientDelphine Borchiellini, Denis MailletCancers|December 17, 2024
Sex Disparities in Bladder Cancer Diagnosis and TreatmentGéraldine Pignot, Philippe Barthélémy, Delphine BorchielliniCancer Treatment Reviews|March 6, 2012
The impact of pharmacogenetics on radiation therapy outcome in cancer patients. A focus on DNA damage response genesDelphine Borchiellini, Marie-Christine Etienne-Grimaldi, Juliette Thariat, et al.Scientific Reports|November 1, 2019
LC-MS based metabolomic profiling for renal cell carcinoma histologic subtypesLun Jing, Jean-Marie Guigonis, Delphine Borchiellini, et al.Cancers|July 1, 2020
Comparative Efficacy of First-Line Immune-Based Combination Therapies in Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-AnalysisReza Elaidi, Letuan Phan, Delphine Borchiellini, et al.Scientific Reports|June 13, 2020
Author Correction: Hyperprogression under Immune Checkpoint Inhibitor: a potential role for germinal immunogeneticsSadal Refae, Jocelyn Gal, Patrick Brest, et al.Scientific Reports|February 29, 2020
Hyperprogression under Immune Checkpoint Inhibitor: a potential role for germinal immunogeneticsSadal Refae, Jocelyn Gal, Patrick Brest, et al.Investigational New Drugs|August 13, 2019
Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitorsSadal Refae, Jocelyn Gal, Nathalie Ebran, et al.Pageof 8